This report aims to provide a comprehensive presentation of the global market for Plasma Derived Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Derived Drugs. This report contains market size and forecasts of Plasma Derived Drugs in global, including the following market information:
Global Plasma Derived Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Plasma Derived Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Plasma Derived Drugs companies in 2022 (%)
The global Plasma Derived Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immunoglobulins Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Plasma Derived Drugs include Grifols, S.A., Octapharma, Antares Pharma and CSL Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Plasma Derived Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Plasma Derived Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Plasma Derived Drugs Market Segment Percentages, by Type, 2022 (%)
Immunoglobulins
Albumins
Clotting Factors
Others
Global Plasma Derived Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Plasma Derived Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Diagnostic Centers
Others
Global Plasma Derived Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Plasma Derived Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Plasma Derived Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Plasma Derived Drugs revenues share in global market, 2022 (%)
Key companies Plasma Derived Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Plasma Derived Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Grifols, S.A.
Octapharma
Antares Pharma
CSL Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Plasma Derived Drugs, market overview.
Chapter 2: Global Plasma Derived Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Plasma Derived Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Plasma Derived Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Plasma Derived Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Plasma Derived Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Plasma Derived Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Plasma Derived Drugs Overall Market Size
2.1 Global Plasma Derived Drugs Market Size: 2022 VS 2029
2.2 Global Plasma Derived Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Plasma Derived Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Plasma Derived Drugs Players in Global Market
3.2 Top Global Plasma Derived Drugs Companies Ranked by Revenue
3.3 Global Plasma Derived Drugs Revenue by Companies
3.4 Global Plasma Derived Drugs Sales by Companies
3.5 Global Plasma Derived Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Plasma Derived Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Plasma Derived Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Plasma Derived Drugs Players in Global Market
3.8.1 List of Global Tier 1 Plasma Derived Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Plasma Derived Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Plasma Derived Drugs Market Size Markets, 2022 & 2029
4.1.2 Immunoglobulins
4.1.3 Albumins
4.1.4 Clotting Factors
4.1.5 Others
4.2 By Type - Global Plasma Derived Drugs Revenue & Forecasts
4.2.1 By Type - Global Plasma Derived Drugs Revenue, 2018-2023
4.2.2 By Type - Global Plasma Derived Drugs Revenue, 2024-2029
4.2.3 By Type - Global Plasma Derived Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Plasma Derived Drugs Sales & Forecasts
4.3.1 By Type - Global Plasma Derived Drugs Sales, 2018-2023
4.3.2 By Type - Global Plasma Derived Drugs Sales, 2024-2029
4.3.3 By Type - Global Plasma Derived Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Plasma Derived Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Plasma Derived Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Speciality Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Diagnostic Centers
5.1.6 Others
5.2 By Application - Global Plasma Derived Drugs Revenue & Forecasts
5.2.1 By Application - Global Plasma Derived Drugs Revenue, 2018-2023
5.2.2 By Application - Global Plasma Derived Drugs Revenue, 2024-2029
5.2.3 By Application - Global Plasma Derived Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Plasma Derived Drugs Sales & Forecasts
5.3.1 By Application - Global Plasma Derived Drugs Sales, 2018-2023
5.3.2 By Application - Global Plasma Derived Drugs Sales, 2024-2029
5.3.3 By Application - Global Plasma Derived Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Plasma Derived Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Plasma Derived Drugs Market Size, 2022 & 2029
6.2 By Region - Global Plasma Derived Drugs Revenue & Forecasts
6.2.1 By Region - Global Plasma Derived Drugs Revenue, 2018-2023
6.2.2 By Region - Global Plasma Derived Drugs Revenue, 2024-2029
6.2.3 By Region - Global Plasma Derived Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Plasma Derived Drugs Sales & Forecasts
6.3.1 By Region - Global Plasma Derived Drugs Sales, 2018-2023
6.3.2 By Region - Global Plasma Derived Drugs Sales, 2024-2029
6.3.3 By Region - Global Plasma Derived Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Plasma Derived Drugs Revenue, 2018-2029
6.4.2 By Country - North America Plasma Derived Drugs Sales, 2018-2029
6.4.3 US Plasma Derived Drugs Market Size, 2018-2029
6.4.4 Canada Plasma Derived Drugs Market Size, 2018-2029
6.4.5 Mexico Plasma Derived Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Plasma Derived Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Plasma Derived Drugs Sales, 2018-2029
6.5.3 Germany Plasma Derived Drugs Market Size, 2018-2029
6.5.4 France Plasma Derived Drugs Market Size, 2018-2029
6.5.5 U.K. Plasma Derived Drugs Market Size, 2018-2029
6.5.6 Italy Plasma Derived Drugs Market Size, 2018-2029
6.5.7 Russia Plasma Derived Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Plasma Derived Drugs Market Size, 2018-2029
6.5.9 Benelux Plasma Derived Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Plasma Derived Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Plasma Derived Drugs Sales, 2018-2029
6.6.3 China Plasma Derived Drugs Market Size, 2018-2029
6.6.4 Japan Plasma Derived Drugs Market Size, 2018-2029
6.6.5 South Korea Plasma Derived Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Plasma Derived Drugs Market Size, 2018-2029
6.6.7 India Plasma Derived Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Plasma Derived Drugs Revenue, 2018-2029
6.7.2 By Country - South America Plasma Derived Drugs Sales, 2018-2029
6.7.3 Brazil Plasma Derived Drugs Market Size, 2018-2029
6.7.4 Argentina Plasma Derived Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Plasma Derived Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Plasma Derived Drugs Sales, 2018-2029
6.8.3 Turkey Plasma Derived Drugs Market Size, 2018-2029
6.8.4 Israel Plasma Derived Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Plasma Derived Drugs Market Size, 2018-2029
6.8.6 UAE Plasma Derived Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Grifols, S.A.
7.1.1 Grifols, S.A. Company Summary
7.1.2 Grifols, S.A. Business Overview
7.1.3 Grifols, S.A. Plasma Derived Drugs Major Product Offerings
7.1.4 Grifols, S.A. Plasma Derived Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Grifols, S.A. Key News & Latest Developments
7.2 Octapharma
7.2.1 Octapharma Company Summary
7.2.2 Octapharma Business Overview
7.2.3 Octapharma Plasma Derived Drugs Major Product Offerings
7.2.4 Octapharma Plasma Derived Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Octapharma Key News & Latest Developments
7.3 Antares Pharma
7.3.1 Antares Pharma Company Summary
7.3.2 Antares Pharma Business Overview
7.3.3 Antares Pharma Plasma Derived Drugs Major Product Offerings
7.3.4 Antares Pharma Plasma Derived Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Antares Pharma Key News & Latest Developments
7.4 CSL Limited
7.4.1 CSL Limited Company Summary
7.4.2 CSL Limited Business Overview
7.4.3 CSL Limited Plasma Derived Drugs Major Product Offerings
7.4.4 CSL Limited Plasma Derived Drugs Sales and Revenue in Global (2018-2023)
7.4.5 CSL Limited Key News & Latest Developments
8 Global Plasma Derived Drugs Production Capacity, Analysis
8.1 Global Plasma Derived Drugs Production Capacity, 2018-2029
8.2 Plasma Derived Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Plasma Derived Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Plasma Derived Drugs Supply Chain Analysis
10.1 Plasma Derived Drugs Industry Value Chain
10.2 Plasma Derived Drugs Upstream Market
10.3 Plasma Derived Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Plasma Derived Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Plasma Derived Drugs in Global Market
Table 2. Top Plasma Derived Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Plasma Derived Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Plasma Derived Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Plasma Derived Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Plasma Derived Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Plasma Derived Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Plasma Derived Drugs Product Type
Table 9. List of Global Tier 1 Plasma Derived Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Plasma Derived Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Plasma Derived Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Plasma Derived Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Plasma Derived Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Plasma Derived Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Plasma Derived Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Plasma Derived Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Plasma Derived Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Plasma Derived Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Plasma Derived Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Plasma Derived Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Plasma Derived Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Plasma Derived Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Plasma Derived Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Plasma Derived Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Plasma Derived Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Plasma Derived Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Plasma Derived Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Plasma Derived Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Plasma Derived Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Plasma Derived Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Plasma Derived Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Plasma Derived Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Plasma Derived Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Plasma Derived Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Plasma Derived Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Plasma Derived Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Plasma Derived Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Plasma Derived Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Plasma Derived Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Plasma Derived Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Plasma Derived Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Plasma Derived Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Plasma Derived Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Plasma Derived Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Plasma Derived Drugs Sales, (K Units), 2024-2029
Table 46. Grifols, S.A. Company Summary
Table 47. Grifols, S.A. Plasma Derived Drugs Product Offerings
Table 48. Grifols, S.A. Plasma Derived Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Grifols, S.A. Key News & Latest Developments
Table 50. Octapharma Company Summary
Table 51. Octapharma Plasma Derived Drugs Product Offerings
Table 52. Octapharma Plasma Derived Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Octapharma Key News & Latest Developments
Table 54. Antares Pharma Company Summary
Table 55. Antares Pharma Plasma Derived Drugs Product Offerings
Table 56. Antares Pharma Plasma Derived Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Antares Pharma Key News & Latest Developments
Table 58. CSL Limited Company Summary
Table 59. CSL Limited Plasma Derived Drugs Product Offerings
Table 60. CSL Limited Plasma Derived Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. CSL Limited Key News & Latest Developments
Table 62. Plasma Derived Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 63. Global Plasma Derived Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Plasma Derived Drugs Production by Region, 2018-2023 (K Units)
Table 65. Global Plasma Derived Drugs Production by Region, 2024-2029 (K Units)
Table 66. Plasma Derived Drugs Market Opportunities & Trends in Global Market
Table 67. Plasma Derived Drugs Market Drivers in Global Market
Table 68. Plasma Derived Drugs Market Restraints in Global Market
Table 69. Plasma Derived Drugs Raw Materials
Table 70. Plasma Derived Drugs Raw Materials Suppliers in Global Market
Table 71. Typical Plasma Derived Drugs Downstream
Table 72. Plasma Derived Drugs Downstream Clients in Global Market
Table 73. Plasma Derived Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Plasma Derived Drugs Segment by Type in 2022
Figure 2. Plasma Derived Drugs Segment by Application in 2022
Figure 3. Global Plasma Derived Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Plasma Derived Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Plasma Derived Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Plasma Derived Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Plasma Derived Drugs Revenue in 2022
Figure 9. By Type - Global Plasma Derived Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Plasma Derived Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Plasma Derived Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Plasma Derived Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Plasma Derived Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Plasma Derived Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Plasma Derived Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Plasma Derived Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Plasma Derived Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Plasma Derived Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Plasma Derived Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Plasma Derived Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Plasma Derived Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Plasma Derived Drugs Sales Market Share, 2018-2029
Figure 23. US Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Plasma Derived Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Plasma Derived Drugs Sales Market Share, 2018-2029
Figure 28. Germany Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Plasma Derived Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Plasma Derived Drugs Sales Market Share, 2018-2029
Figure 37. China Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Plasma Derived Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Plasma Derived Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Plasma Derived Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Plasma Derived Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Plasma Derived Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Plasma Derived Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Plasma Derived Drugs by Region, 2022 VS 2029
Figure 54. Plasma Derived Drugs Industry Value Chain
Figure 55. Marketing Channels
